J.P. Morgan Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $117
J.P. Morgan has reiterated its Hold rating on Zimmer Biomet Holdings (ZBH.US) and increased its target price for the stock to $117. This indicates a maintained neutral outlook with a slightly more optimistic valuation for the company's shares.